AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next
NEW YORK, Jan 6, 2026, 08:02 EST — Premarket AbbVie shares were flat in premarket trading on Tuesday after the drugmaker said Health Canada had approved its hepatitis C pill Maviret for both acute and chronic infection. AbbVie stock last